Inside CAS: Strategy, Advocacy and the Road Ahead

June 7, 2026, 10:00 am - 11:30 am

In this session, participants will be presented with an overview of CAS’ new Strategic Plan 2025-2030, which maps out the future of CAS, the delivery of our mission pillars, provides details of 2025’s success and current year plans including recent advocacy initiatives. Participants will also receive a current lay-of the political land overview by CAS’ Government Relations Firm GPA and will hear how CAS political asks are being received and the overall perception of CAS by both provincial and federal policy makers.
1.I attended this session:(Required.)
2.Overall Session Evaluation
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
The objectives were clearly stated 
The stated objectives were met 
I acquired new skills and/or knowledge
I was introduced to new perspectives on my current practice
The content was relevant to my learning needs
This session promoted interaction (i.e., Q&A, polling etc.)
3.Which CanMEDS roles were addressed?
4.Moderator: Dr. Giuseppe Fuda
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
The moderator was organized and managed the  session well
5.Speaker: Dr. Giuseppe Fuda
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
Communicated clearly and effectively
Was knowledgeable about this topic
Used clear audiovisual aids, which enhanced the presentation
I would attend another presentation by this speaker in the future
6.Overall, how would you rate the quality and effectiveness of the speaker's presentation with 1 being poor and 10 being excellent?
0
5
10
7.Speaker: Dr. Andrew Retfalvi
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
Communicated clearly and effectively
Was knowledgeable about this topic
Used clear audiovisual aids, which enhanced the presentation
I would attend another presentation by this speaker in the future
8.Overall, how would you rate the quality and effectiveness of the speaker's presentation with 1 being poor and 10 being excellent?
0
5
10
9.The session and presenter(s) were balanced and free from commercial bias
10.Please provide any additional comments or suggestions regarding this session, moderator(s), and speaker(s).
Thank you for completing the evaluation!